Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

This study has been completed.

Study NCT00217555 Information provided by Fred Hutchinson Cancer Research Center

First Received: September 20, 2005 Last Updated: September 20, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)

Publications: